Bart A. Ostyn
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey.
Journal: The Lancet. Global health
Published: September 03, 2019
Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
Journal: PLoS neglected tropical diseases
Published: September 14, 2018
Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India.
Journal: Tropical medicine & international health : TM & IH
Published: June 09, 2017
Treatment of visceral leishmaniasis: pitfalls and stewardship.
Journal: The Lancet. Infectious diseases
Published: February 08, 2016
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent.
Journal: eLife
Published: October 27, 2015
Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; methodological lessons learned from a cluster randomised controlled trial.
Journal: PLoS neglected tropical diseases
Published: April 10, 2015
Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts.
Journal: PLoS neglected tropical diseases
Published: March 09, 2015
Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance System.
Journal: International journal of epidemiology
Published: September 05, 2014
Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure.
Journal: The Journal of infectious diseases
Published: January 21, 2014
Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia.
Journal: PloS one
Published: November 22, 2013
Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.
Journal: PLoS neglected tropical diseases
Published: October 16, 2013
Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain.
Journal: mBio
Published: October 10, 2013
Last Updated: 09/26/2026